Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica

被引：0
|
作者：
Araki, Manabu [1 ]
Matsuoka, Takako [1 ]
Aranami, Toshimasa [1 ]
Nakamura, Masakazu [1 ]
Okamoto, Tomoko [1 ]
Murata, Miho [1 ]
Miyake, Sachiko [1 ]
Yamamura, Takashi [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-7
引用
收藏
页码：911 / 912
页数：2
相关论文
共 50 条
  • [1] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab in three patients with neuromyelitis optica
    Araki, M.
    Aranami, T.
    Matsuoka, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 417 - 417
  • [2] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab for the treatment of neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 947 - 947
  • [3] Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
    Araki, Manabu
    Matsuoka, Takako
    Miyamoto, Katsuichi
    Kusunoki, Susumu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Aranami, Toshimasa
    Yamamura, Takashi
    [J]. NEUROLOGY, 2014, 82 (15) : 1302 - 1306
  • [4] Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
    Araki, Manabu
    Aranami, Toshimasa
    Matsuoka, Takako
    Nakamura, Masakazu
    Miyake, Sachiko
    Yamamura, Takashi
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (04) : 827 - 831
  • [5] How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?
    Matsuoka, T.
    Araki, M.
    Yamaguchi, H.
    Sato, W.
    Miyamoto, K.
    Kusunoki, S.
    Gold, R.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1000 - 1001
  • [6] Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 326 - 327
  • [7] Immunomodulatory effect of anti-IL6 receptor monoclonal antibody tocilizumab in patients with neuromyelitis optica
    Matsuoka, T.
    Chiba, A.
    Aranami, T.
    Araki, M.
    Nakamura, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 463 - 464
  • [8] Tocilizumab - A humanized anti-IL-6 receptor monoclonal antibody for the treatment of rheumatoid arthritis
    Schlesselman, Lauren S.
    Hussey, Aaron P.
    [J]. FORMULARY, 2008, 43 (08) : 272 - 279
  • [9] Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 122
  • [10] In Vitro Cellular Profiling of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, Reveals a Distinct Phenotypic Signature Compared to Tocilizumab, an Anti-IL-6 Receptor Monoclonal Antibody
    Chavele, Konstantia-Maria
    Gardner, Debbie
    Loza, Matthew J.
    Dasgupta, Bidisha
    Sims, Martin
    Shealy, David
    Reid, Juliet
    Rao, Ravi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345